Es gab 50 kürzliche Insider-Transaktionen für Elevation Oncology, Inc. (ELEV), darunter 25 Käufe und 21 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $1.77M und die gesamten Insider-Verkäufe auf $18.37K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Ferra Joseph J Jr, Clackson Timothy P, Elms Steve. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — ELEV
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-06-16 |
Ferra Joseph J Jr |
Chief Executive Officer |
Optionsausübung (Verkauf) |
12,560 |
- |
- |
- |
| 2025-06-05 |
Clackson Timothy P |
Director |
RSU-Zuteilung |
35,000 |
$0.31 |
$10.68K |
35,000 |
| 2025-06-05 |
Elms Steve |
Director |
RSU-Zuteilung |
35,000 |
$0.31 |
$10.68K |
35,000 |
| 2025-06-05 |
Carruthers R Michael |
Director |
RSU-Zuteilung |
35,000 |
$0.31 |
$10.68K |
35,000 |
| 2025-06-05 |
Cherrington Julie M |
Director |
RSU-Zuteilung |
35,000 |
$0.31 |
$10.68K |
35,000 |
| 2025-06-05 |
Sandler Alan B. |
Director |
RSU-Zuteilung |
35,000 |
$0.31 |
$10.68K |
35,000 |
| 2025-06-05 |
Mootz Darcy |
Director |
RSU-Zuteilung |
35,000 |
$0.31 |
$10.68K |
35,000 |
| 2025-05-15 |
Ferra Joseph J Jr |
Chief Executive Officer |
Optionsausübung (Verkauf) |
6,250 |
- |
- |
68,750 |
| 2025-05-15 |
Furlong Tammy |
Chief Financial Officer |
Optionsausübung (Verkauf) |
300 |
- |
- |
2,100 |
| 2025-03-16 |
Ferra Joseph J Jr |
Chief Executive Officer |
Optionsausübung (Verkauf) |
12,562 |
- |
- |
12,560 |
| 2025-02-15 |
Ferra Joseph J Jr |
Chief Executive Officer |
Optionsausübung (Verkauf) |
25,000 |
- |
- |
75,000 |
| 2025-02-15 |
Dornan David |
Chief Scientific Officer |
RSU-Steuereinbehalt |
4,152 |
$0.67 |
$2.79K |
5,223 |
| 2025-02-15 |
Jansen Valerie Malyvanh |
Chief Medical Officer |
RSU-Steuereinbehalt |
5,189 |
$0.67 |
$3.49K |
12,311 |
| 2025-02-15 |
Furlong Tammy |
Chief Financial Officer |
Optionsausübung (Verkauf) |
300 |
- |
- |
2,400 |
| 2024-12-16 |
Ferra Joseph J Jr |
Chief Executive Officer |
Optionsausübung (Verkauf) |
12,563 |
- |
- |
25,122 |
| 2024-11-15 |
Furlong Tammy |
Chief Financial Officer |
RSU-Steuereinbehalt |
98 |
$0.53 |
$52.09 |
1,410 |
| 2024-09-16 |
Ferra Joseph J Jr |
Chief Executive Officer |
Optionsausübung (Verkauf) |
12,562 |
- |
- |
37,685 |
| 2024-08-15 |
Furlong Tammy |
Chief Financial Officer |
RSU-Steuereinbehalt |
89 |
$0.72 |
$64.26 |
1,208 |
| 2024-06-16 |
Ferra Joseph J Jr |
Chief Executive Officer |
Optionsausübung (Verkauf) |
12,562 |
- |
- |
50,247 |
| 2024-06-13 |
Clackson Timothy P |
Director |
RSU-Zuteilung |
35,000 |
$3.35 |
$117.25K |
35,000 |
| 2024-06-13 |
Elms Steve |
Director |
RSU-Zuteilung |
35,000 |
$3.35 |
$117.25K |
35,000 |
| 2024-06-13 |
Carruthers R Michael |
Director |
RSU-Zuteilung |
35,000 |
$3.35 |
$117.25K |
35,000 |
| 2024-06-13 |
Cherrington Julie M |
Director |
RSU-Zuteilung |
35,000 |
$3.35 |
$117.25K |
35,000 |
| 2024-06-13 |
Sandler Alan B. |
Director |
RSU-Zuteilung |
35,000 |
$3.35 |
$117.25K |
35,000 |
| 2024-06-13 |
Mootz Darcy |
Director |
RSU-Zuteilung |
35,000 |
$3.35 |
$117.25K |
35,000 |
| 2024-05-15 |
Furlong Tammy |
Chief Financial Officer |
RSU-Steuereinbehalt |
100 |
$3.73 |
$373.00 |
997 |
| 2024-03-16 |
Ferra Joseph J Jr |
Chief Executive Officer |
Optionsausübung (Verkauf) |
12,562 |
- |
- |
62,809 |
| 2024-02-29 |
Cherrington Julie M |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-02-29 |
Cherrington Julie M |
Director |
RSU-Zuteilung |
55,000 |
$4.41 |
$242.55K |
55,000 |
| 2024-02-29 |
Sandler Alan B. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-02-29 |
Sandler Alan B. |
Director |
RSU-Zuteilung |
55,000 |
$4.41 |
$242.55K |
55,000 |
| 2024-02-15 |
Jansen Valerie Malyvanh |
Chief Medical Officer |
Optionsausübung (Verkauf) |
17,500 |
- |
- |
52,500 |
| 2024-02-15 |
Ferra Joseph J Jr |
Chief Executive Officer |
RSU-Zuteilung |
100,000 |
- |
- |
100,000 |
| 2024-02-15 |
Dornan David |
Chief Scientific Officer |
RSU-Zuteilung |
37,500 |
- |
- |
37,500 |
| 2024-02-15 |
Jansen Valerie Malyvanh |
Chief Medical Officer |
RSU-Zuteilung |
70,000 |
- |
- |
70,000 |
| 2024-02-15 |
Furlong Tammy |
Chief Financial Officer |
RSU-Steuereinbehalt |
403 |
$2.77 |
$1.12K |
797 |
| 2024-01-18 |
Mootz Darcy |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-01-18 |
Mootz Darcy |
Director |
RSU-Zuteilung |
55,000 |
$2.74 |
$150.7K |
55,000 |
| 2023-12-16 |
Ferra Joseph J Jr |
Chief Executive Officer |
Optionsausübung (Verkauf) |
12,563 |
- |
- |
75,371 |
| 2023-09-16 |
Ferra Joseph J Jr |
Chief Executive Officer |
RSU-Steuereinbehalt |
4,773 |
$0.73 |
$3.47K |
70,101 |
| 2023-09-01 |
Clackson Timothy P |
Director |
Schenkung (gegeben) |
15,777 |
- |
- |
- |
| 2023-07-12 |
Ferra Joseph J Jr |
Chief Executive Officer |
RSU-Zuteilung |
35,000 |
$1.51 |
$52.85K |
35,000 |
| 2023-07-12 |
Furlong Tammy |
Chief Financial Officer |
Veräußerung |
4,800 |
- |
- |
- |
| 2023-07-12 |
Furlong Tammy |
Chief Financial Officer |
RSU-Zuteilung |
53,433 |
$1.51 |
$80.68K |
53,433 |
| 2023-06-16 |
Clackson Timothy P |
Director |
RSU-Zuteilung |
31,238 |
$1.47 |
$45.92K |
31,238 |
| 2023-06-16 |
Carruthers R Michael |
Director |
RSU-Zuteilung |
31,238 |
$1.47 |
$45.92K |
31,238 |
| 2023-06-16 |
Aisling Capital Iv, Lp |
10 Percent Owner |
RSU-Zuteilung |
31,238 |
$1.47 |
$45.92K |
31,238 |
| 2023-06-16 |
Ferra Joseph J Jr |
Interim CEO & CFO |
RSU-Steuereinbehalt |
4,773 |
$1.47 |
$7.02K |
62,312 |
| 2023-06-16 |
Hu Lori |
Director |
RSU-Zuteilung |
31,238 |
$1.47 |
$45.92K |
31,238 |
| 2023-06-16 |
Walsh Colin |
Director |
RSU-Zuteilung |
31,238 |
$1.47 |
$45.92K |
31,238 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
